HelloVideos

Most Watched Onclivetv

Dr. Roland on Findings From a Phase 2 Study With Neoadjuvant Checkpoint Blockade in Sarcoma

Dr. Roland on Findings From a Phase 2 Study With Neoadjuvant Checkpoint Blockade in Sarcoma

Wed, 2nd Sep 20
  
 
Dr. Pennell on the Evolution of Targeting HER2 in Lung Cancer

Dr. Pennell on the Evolution of Targeting HER2 in Lung Cancer

Wed, 2nd Sep 20
  
 
Dr. VanderWalde on Utility of Radiation Therapy in Rectal Cancer

Dr. VanderWalde on Utility of Radiation Therapy in Rectal Cancer

Wed, 2nd Sep 20
  
 
Current and Future Directions in Metastatic Pancreatic Cancer

Current and Future Directions in Metastatic Pancreatic Cancer

Wed, 2nd Sep 20
  
 
Dr. Maddocks on Emerging Therapies in Follicular Lymphoma

Dr. Maddocks on Emerging Therapies in Follicular Lymphoma

Tue, 1st Sep 20
  
 
Dr. Richard on the Evolving Armamentarium in Multiple Myeloma

Dr. Richard on the Evolving Armamentarium in Multiple Myeloma

Tue, 1st Sep 20
  
 
Dr. Halfdanarson on the KEYNOTE-177 Trial in MSI-H/dMMR mCRC

Dr. Halfdanarson on the KEYNOTE-177 Trial in MSI-H/dMMR mCRC

Tue, 1st Sep 20
  
 
Dr. Han on the Importance of Risk Stratification in HER2+ Breast Cancer

Dr. Han on the Importance of Risk Stratification in HER2+ Breast Cancer

Tue, 1st Sep 20
  
 
Dr. Alkharabsheh on the Goals of Treatment in MPNs

Dr. Alkharabsheh on the Goals of Treatment in MPNs

Tue, 1st Sep 20
  
 
Dr. Soliman the Utility of ADCs in Breast Cancer

Dr. Soliman the Utility of ADCs in Breast Cancer

Tue, 1st Sep 20
  
 
MURANO Trial Update in R/R CLL

MURANO Trial Update in R/R CLL

Tue, 1st Sep 20
  
 
Utility of MRD Testing in CLL Management

Utility of MRD Testing in CLL Management

Tue, 1st Sep 20
  
 
Dr. DiNardo on the FDA Approval of Oral Azacitidine in AML

Dr. DiNardo on the FDA Approval of Oral Azacitidine in AML

Tue, 1st Sep 20
  
 
Dr. Grothey on Biomarkers to Inform Metastatic CRC Treatment Decisions

Dr. Grothey on Biomarkers to Inform Metastatic CRC Treatment Decisions

Tue, 1st Sep 20
  
 
Dr. Richter on the Utility of Isatuximab in Relapsed/Refractory Myeloma

Dr. Richter on the Utility of Isatuximab in Relapsed/Refractory Myeloma

Tue, 1st Sep 20
  
 
Forged Through Fire: Nurses Are More Needed Than Ever Before

Forged Through Fire: Nurses Are More Needed Than Ever Before

Tue, 1st Sep 20
  
 
Dr. Gronchi on the Toxicity Profile of Trabectedin Plus Radiotherapy in Sarcoma

Dr. Gronchi on the Toxicity Profile of Trabectedin Plus Radiotherapy in Sarcoma

Tue, 1st Sep 20
  
 
Dr. O’Regan on the Utility of CDK4/6 Inhibitors in Breast Cancer

Dr. O’Regan on the Utility of CDK4/6 Inhibitors in Breast Cancer

Mon, 31st Aug 20
  
 
Dr. Hamilton on Recent Advances in HER2+ Breast Cancer

Dr. Hamilton on Recent Advances in HER2+ Breast Cancer

Mon, 31st Aug 20
  
 
Dr. Lai on the Potential Benefits of Venetoclax in AML

Dr. Lai on the Potential Benefits of Venetoclax in AML

Mon, 31st Aug 20
  
 
Load More Videos
x
This website is using cookies for providing you best experience. More info. That's Fine